Trump to impose steep tariffs on steel, aluminum; stokes trade war fears

President Donald Trump said he would impose hefty tariffs on imported steel and aluminum. (AP)
Updated 02 March 2018
Follow

Trump to impose steep tariffs on steel, aluminum; stokes trade war fears

WASHINGTON: President Donald Trump announced on Thursday he would impose hefty tariffs on imported steel and aluminum to protect US producers, risking retaliation from major trade partners like China, Europe and neighboring Canada.
Fears of a trade war triggered a selloff on Wall Street.
Trump said the duties, 25 percent on steel imports and 10 percent on aluminum, would be formally announced next week, although White House officials later said some details still needed to be ironed out.
Trump believes the tariffs will safeguard American jobs, but many economists say the impact of price increases for users of steel and aluminum, such as the auto and oil industries, will destroy more jobs than curbs on imports create.
“We’re going to build our steel industry back and our aluminum industry back,” Trump said.
Shares of US domestic steel and aluminum makers rallied, but shares of companies ranging from auto makers to airplane makers fell on the potential impact of the higher costs they will have to pay for the metals.
The announcement came after what one person with direct knowledge of the discussions described as a night of “chaos” in the White House due to frequent switching of positions in the administration.
The tariffs were sharply criticized by some senior Republican lawmakers as well as industries ranging from autos to oil to construction equipment. A major concern is that US farm exports could be hit hard in retaliation by steel-exporting countries.
“Every time you do this, you get a retaliation. Agriculture is the number one target. I think this is terribly counterproductive for the agriculture economy,” said Senator Pat Roberts, who chairs the chamber’s agriculture committee.

Canada ready to respond
China has already threatened to curb imports of US soybeans, and the European Union has said it will consider action as well. President Xi Jinping’s top economic adviser, Liu He, held talks with the Trump administration in Washington on Thursday.
The discussion was described as “frank and constructive,” by a White House official, and focused on “ways to ensure fair and reciprocal trade.”
Trade tensions between the United States and China have risen since Trump took office in 2017.
The tariffs will not directly hit China that hard. Data shows that Canada supplies 16 percent of US demand for steel versus China’s 2 percent and is by far the largest steel exporter, followed by Brazil and South Korea.
Other countries were already looking at how to respond.
“Should restrictions be imposed on Canadian steel and aluminum products, Canada will take responsive measures to defend its trade interests and workers,” the country’s foreign affairs minister, Chrystia Freeland, said in a sharply worded statement.
Brazil’s industry ministry said Brazil would consider taking action on its own over the tariffs or in concert with other countries. Shares of two of its largest steel makers, Cia Siderurgica Nacional and Usiminas, sold off, closing down 4.4 percent and 4.2 percent, respectively.
Washington is already engaged in a dispute with Canada and Mexico over its proposed revision to the North American Free Trade Agreement, and months of tense talks have failed to produce any meaningful progress.
Asked whether there would be exemptions for any countries, White House spokeswoman Sarah Sanders said she would not get into any details ahead of next week’s announcement. She said the tariffs were still being finalized.
Although China only accounts for a small fraction of US steel imports, its massive industry expansion has helped produce a global glut of steel that has driven down prices.
Wall Street trading reflected the divergent impact of the tariffs. Steel makers rose, with AK Steel Holding up 9.5 percent, US Steel Corp. up 5.7 percent and Nucor up 3.3 percent. Companies that are big users of steel fell. Ford Motor Co. shed 3 percent and General Motors Co. fell 4 percent.
But the overall trend was down, with the Dow Jones Industrial Average falling 1.7 percent and the S&P 500 index down 1.3 percent.
Though the administration says duties would protect US industry, critics say they would raise costs for industry and fail to deliver on Trump’s campaign pledge to boost domestic jobs.
The tariffs were a victory for the trade hawks in Trump’s administration, including White House trade adviser Peter Navarro, who has been rising in importance, and a setback for those who fear repercussions, such as top economic adviser Gary Cohn.
It had appeared unlikely that Trump would announce the tariffs on Thursday after a night of back and forth inside the administration.
“There was a lot of movement within the past 12, 16 hours,” said the source who had knowledge of the discussions but who declined to be named due to the sensitivity of the issue.
“It was going to happen. It wasn’t going to happen and then it did happen,” the source said.
The administration also cited national security interests for its action, saying the United States needs domestic supply for its tanks and warships. But the Department of Defense had recommended targeted steel tariffs and a delay in aluminum duties.

Few more jobs from tariffs
While American steelmakers lost three quarters of their jobs between 1962 and 2005, a major study by the American Economic Association showed that much of this reflected improved production technology, with output per worker rising fivefold.
“Thus, even if trade protection leads to increased domestic production, increases in employment may be far less than many hope,” a report from the independent Econofact economist network said last week.
“Across many states, the number of jobs adversely affected in these steel-using industries could far exceed any steel jobs saved,” Econofact warned.
The overall impact on the US economy is likely to be muted, barring a major trade war, with steel and aluminum imports accounting for just 2 percent of the overall total.
Investment bank Barclays estimated the tariffs would add 0.1 percentage point to core inflation over a period of time and cut economic growth by 0.1-0.2 percentage point, which would be more than offset by Trump’s fiscal stimulus.


Bitter pill: Taliban govt shakes up Afghan medicine market

Updated 3 sec ago
Follow

Bitter pill: Taliban govt shakes up Afghan medicine market

  • Afghanistan’s decision to overhaul its medicine market was meant to improve quality and boost domestic production, but industry specialists say the swift changes have led to a litany of problems
KABUL: Afghanistan’s decision to overhaul its medicine market was meant to improve quality and boost domestic production, but industry specialists say the swift changes have led to a litany of problems.
The Taliban authorities announced in November that the decades-long dependency on medicine imports from Pakistan would soon end, a step taken after deadly border clashes with their neighbor.
After the ban came into effect this month, finance ministry spokesman Abdul Qayoom Naseer told AFP that the government urged all importers to find “alternative and legal” sources to replace Pakistani supplies.
Despite a three-month grace period to end existing contracts and clear customs, the shift presents a huge challenge for a country which had imported more than half its medicine from Pakistan.
“Some of the prices have increased, some of them are short (unavailable), it has created a lot of problems for people,” said Mujeebullah Afzali, a pharmacist in the capital, Kabul.
Drugs now have to come from elsewhere, increasing transit time and transport costs, and adding logistical complexities.
The pharmacist said he had begun importing medicine through the Islam Qala crossing on the Iranian border, “which increased the transportation fee 10 to 15 percent.”
Transport costs used to account for six to seven percent of total spending on medicine, but this has now risen to 25 to 30 percent, said a person directly involved in the pharmaceutical industry, speaking to AFP on condition of anonymity due to security concerns.
He estimated that the overall losses to business owners had already reached millions of dollars.
“If a medicine was short in the market before, a call was made to Pakistan, and the medicine was delivered in two to three days,” he said.
Whether legally or not, it was “delivered quickly,” he added.
‘Fill the gap’
The illicit trade in pharmaceuticals was a key driver for the overhaul, according to the health ministry.
“The biggest problem with Pakistani medicine was that we used to receive counterfeit and fake medicines,” ministry spokesman Sharafat Zaman told AFP.
He acknowledged it will take some time to shift the market, saying that officials were working with Iran, India, Bangladesh, Uzbekistan, Turkiye, China and Belarus to source medicine.
“India was second in the market, which means that now, through Indian medicines, we can cover the percentage needed,” Zaman said.
And domestic production of 600 medicines has “solved the problems” of many patients, he said.
Afghanistan already produces a variety of serums including antibiotics, according to manufacturer Milli Shifa Pharmaceutical.
The company makes 100,000 bottles daily and “can double the capability” if demand merits, CEO Nasar Ahmad Taraki told AFP.
While Afghanistan has significantly expanded its pharmaceutical sector, domestic output still only meets a small fraction of the overall demand.
The industry source told AFP that the need to import raw materials, the high energy costs and limited infrastructure mean the country cannot be entirely self-sufficient in medicine production.
“If we are provided with the facilities, then we would be able to fill the gap created by Pakistan’s situation,” he said.
Shortages and higher costs
But reshaping an industry nationwide takes more than three months.
Some drugs made in Afghanistan have proven more expensive than those imported from Pakistan, which over the years have gained consumers’ trust.
Some people believe that “if they use Pakistani medicine, they will be cured” — but not if it came from India “or any other country,” the industry source said.
Physicians, meanwhile, are also struggling, a health care provider in Kabul told AFP.
Doctors “must change prescriptions, find suitable alternatives, and spend additional time adjusting treatment plans,” he said, requesting anonymity for security reasons.
The shake-up, which ultimately is meant to end reliance on Pakistan, is complicating care in the short term and could delay treatment, he warned.
“Patients face medicine shortages, frequent switches to alternative products, and sometimes higher costs.”